CABENUVA

viiv healthcare ulc🇨🇦 Health Canada

Approval Id: 5b2ffc01c559b538
Drug Approval Canada Name: CABENUVA
Product Name: CABENUVA
Status: Marketed
Status Date: 2020-09-21
Original Market Date: 2020-09-21
Din: 02497220
Drug Class: Human
Dosage Form: Kit , Suspension (Extended-Release)
Route Of Administration: Intramuscular
Schedule: Prescription
Ahfs: 08:18.08.12
Atc Original: J05AR ANTIVIRALS FOR TREATMENT OF HIV INFECTIONS, COMBINATIONS
Atc Name: j 05 ar
Aig Number: 0262115001
Company Name: viiv healthcare ulc
Company Address: 1400, 75 Rue Queen, Montreal, Quebec, Canada, H3C 2N6

RILPIVIRINE

300 MG / ML

CABOTEGRAVIR

200 MG / ML

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

5b2ffc01c559b538

Type

Standard